AJP - Gastrointestinal and Liver Physiology, Vol 257, Issue 2 299-G307, Copyright © 1989 by American Physiological Society

ARTICLES

Mucosal arachidonate metabolism and intestinal ischemia-reperfusion injury

M. J. Mangino, C. B. Anderson, M. K. Murphy, E. Brunt and J. Turk
Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110.

Mucosal arachidonic acid metabolism was examined after 3 h of ischemia and 1 h of reperfusion in isolated ileal segments in the dog. The cyclooxygenase products thromboxane B2, 6-ketoprostaglandin F1 alpha, and prostaglandin E2 increased by 365%, 97%, and 158%, respectively, after ischemia and reperfusion but were not altered after 3 h of ischemia alone. The potent chemotactic lipoxygenase product leukotriene B4 (LTB4) increased by 687% after ischemia and reperfusion and was not affected by ischemia without reperfusion. In addition, tissue production of the thiol ether leukotrienes (LTC4, LTD4, and LTE4) increased threefold after ischemia and reperfusion. Quantitation of regionally isomeric hydroxy acids produced from arachidonate revealed a 300% increase in 12-hydroxyeicosatetraenoate (12-HETE) after intestinal ischemia and reperfusion without a change in other isomers (15-HETE and 5-HETE). Stereochemical analysis of 12-HETE demonstrated exclusive synthesis of the S-enantiomer. A significant and time-dependent decrease in intestinal blood flow also occurred during reperfusion. Administration of the dual cyclooxygenase-lipoxygenase synthesis inhibitor BW755C (1 mg/kg ia) did not alter time-dependent decreases in blood flow and failed to inhibit eicosanoid synthesis. Histologic examinations of intestinal samples revealed significant mucosal damage associated with ischemia alone and ischemia after reperfusion. This study indicates that intestinal ischemia-reperfusion injury is associated with dramatic alterations in mucosal production of vasoactive eicosanoids and with changes in blood flow that occur during reperfusion but not during ischemia alone. These events may be involved in the pathology characteristic of this injury.

This article has been cited by other articles:

				C. C. Kurtz, S. L. Lindell, M. J. Mangino, and H. V. Carey Hibernation confers resistance to intestinal ischemia-reperfusion injury Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G895 - G901. [Abstract] [Full Text] [PDF]

				L. Zou, B. Attuwaybi, and B. C. Kone Effects of NF-kappa B inhibition on mesenteric ischemia-reperfusion injury Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G713 - G721. [Abstract] [Full Text] [PDF]

				H. T. Hassoun, L. Zou, F. A. Moore, R. A. Kozar, N. W. Weisbrodt, and B. C. Kone alpha -Melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury Am J Physiol Gastrointest Liver Physiol, June 1, 2002; 282(6): G1059 - G1068. [Abstract] [Full Text] [PDF]

				D. Carden, F. Xiao, C. Moak, B. H. Willis, S. Robinson-Jackson, and S. Alexander Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H385 - H392. [Abstract] [Full Text] [PDF]

				L.-W. Fu, H.-L. Pan, and J. C. Longhurst Endogenous histamine stimulates ischemically sensitive abdominal visceral afferents through H1 receptors Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2726 - H2737. [Abstract] [Full Text] [PDF]

				M. J. Mangino, J. E. Mangino, B. Kotadia, and M. Sielczak Effects of the 5-Lipoxygenase Inhibitor A-64077 on Intestinal Hypothermic Organ Preservation Injury J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 950 - 956. [Abstract] [Full Text]